Novolog (Pharm-Up 1966) TASE:NVLG Lagerbericht Finanzdaten des Unternehmens
Novolog (Pharm-Up 1966) Ltd
TASE:NVLG Lagerbericht
Marktkapitalisierung: ₪801.8m
NVLG Aktienübersicht Novolog (Pharm-Up 1966) Ltd erbringt Gesundheitsdienstleistungen in Israel. Mehr Details
Risikoanalyse Alle Risikoprüfungen anzeigen Novolog (Pharm-Up 1966) Ltd Wettbewerber Preisentwicklung & Leistung
Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Novolog (Pharm-Up 1966) Historische Aktienkurse Aktueller Aktienkurs ₪1.57 52-Wochen-Hoch ₪1.70 52-Wochen-Tief ₪1.27 Beta 0.36 11 Monat Veränderung 7.76% 3 Monate Veränderung 11.66% 1 Jahr Veränderung -0.44% 33 Jahre Veränderung -46.58% 5 Jahre Veränderung -5.14% Veränderung seit IPO -3.68%
Aktuelle Nachrichten und Updates
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2024 Results on Nov 20, 2024 Nov 04
Upcoming dividend of ₪0.029 per share Aug 27
Second quarter 2024 earnings released: EPS: ₪0.026 (vs ₪0.023 in 2Q 2023) Aug 22
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2024 Results on Sep 04, 2024 Aug 20 Novolog (Pharm-Up 1966) Ltd, Annual General Meeting, Aug 05, 2024 Jul 02
First quarter 2024 earnings released: EPS: ₪0.024 (vs ₪0.02 loss in 1Q 2023) May 21 Weitere Updates anzeigen
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2024 Results on Nov 20, 2024 Nov 04
Upcoming dividend of ₪0.029 per share Aug 27
Second quarter 2024 earnings released: EPS: ₪0.026 (vs ₪0.023 in 2Q 2023) Aug 22
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2024 Results on Sep 04, 2024 Aug 20 Novolog (Pharm-Up 1966) Ltd, Annual General Meeting, Aug 05, 2024 Jul 02
First quarter 2024 earnings released: EPS: ₪0.024 (vs ₪0.02 loss in 1Q 2023) May 21
Novolog (Pharm-Up 1966) Ltd to Report Q1, 2024 Results on May 21, 2024 May 14
Full year 2023 earnings released: ₪0.082 loss per share (vs ₪0.094 profit in FY 2022) Mar 27
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2023 Results on Mar 26, 2024 Mar 06
New minor risk - Share price stability Feb 10
Third quarter 2023 earnings released: EPS: ₪0.001 (vs ₪0.02 in 3Q 2022) Nov 22
Estimating The Fair Value Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Nov 05
Investor sentiment improves as stock rises 17% Nov 05
Second quarter 2023 earnings released: EPS: ₪0.023 (vs ₪0.024 in 2Q 2022) Aug 23
Be Wary Of Novolog (Pharm-Up 1966) (TLV:NVLG) And Its Returns On Capital Jul 25
First quarter 2023 earnings released: ₪0.02 loss per share (vs ₪0.024 profit in 1Q 2022) Jun 01
Investor sentiment deteriorates as stock falls 15% Mar 30
Full year 2022 earnings released: EPS: ₪0.094 (vs ₪0.084 in FY 2021) Mar 21
Investor sentiment deteriorates as stock falls 17% Feb 26
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2022 Results on Mar 20, 2023 Feb 07
Investor sentiment deteriorates as stock falls 15% Jan 30
Novolog (Pharm-Up 1966) Ltd Appoints Tami Gottlieb as an Independent Non-Executive Director Jan 17
Third quarter 2022 earnings released: EPS: ₪0.02 (vs ₪0.02 in 3Q 2021) Nov 18
Insufficient new directors Nov 16
Novolog (Pharm-Up 1966) Ltd to Report Q3, 2022 Results on Nov 16, 2022 Nov 02
Second quarter 2022 earnings released: EPS: ₪0.024 (vs ₪0.02 in 2Q 2021) Aug 14
Insufficient new directors Aug 01
Novolog (Pharm-Up 1966) Ltd to Report Q2, 2022 Results on Aug 10, 2022 Jul 28
Insufficient new directors Jul 02
First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind May 22
Novolog (Pharm-Up 1966) Ltd to Report Q1, 2022 Results on May 18, 2022 May 19
Investor sentiment improved over the past week Apr 03
Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind Mar 17
Novolog (Pharm-Up 1966) Ltd to Report Q4, 2021 Results on Mar 14, 2022 Feb 25
Third quarter 2021 earnings released: EPS ₪0.022 (vs ₪0.021 in 3Q 2020) Nov 21
I Ran A Stock Scan For Earnings Growth And Novolog (Pharm-Up 1966) (TLV:NVLG) Passed With Ease May 07
Read This Before Buying Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) For Its Dividend Apr 14
Novolog (Pharm-Up 1966)'s (TLV:NVLG) Earnings Are Of Questionable Quality Mar 24
Upcoming dividend of ₪0.032 per share Mar 23
Full year 2020 earnings released: EPS ₪0.086 (vs ₪0.026 in FY 2019) Mar 23
Novolog (Pharm-Up 1966) Ltd to Report Fiscal Year 2020 Results on Mar 17, 2021 Mar 17
Novolog (Pharm-Up 1966) Ltd's (TLV:NVLG) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects? Mar 09
How Much Of Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) Do Insiders Own? Feb 15
New 90-day low: ₪2.76 Feb 01
Update: Novolog (Pharm-Up 1966) (TLV:NVLG) Stock Gained 88% In The Last Three Years Jan 25
Novolog (Pharm-Up 1966) Ltd announced that it has received ILS 119.999999 million in funding Dec 31
How Much Is Novolog (Pharm-Up 1966) Ltd (TLV:NVLG) CEO Getting Paid? Dec 29
With EPS Growth And More, Novolog (Pharm-Up 1966) (TLV:NVLG) Is Interesting Dec 08
Third quarter 2020 earnings released: EPS ₪0.021 Nov 28
Market bids up stock over the past week Nov 18
New 90-day high: ₪3.20 Nov 17
New 90-day high - ₪3.09 Jul 20 Aktionärsrenditen NVLG IL Healthcare IL Markt 7D 4.6% 4.1% 3.5% 1Y -0.4% 17.2% 29.1%
Vollständige Aktionärsrenditen anzeigen
Rendite im Vergleich zur Industrie: NVLG unter dem Niveau der Branche IL Healthcare , die im vergangenen Jahr eine Rendite von 17.2% erzielte.
Rendite vs. Markt: NVLG hinter dem Markt IL zurück, der im vergangenen Jahr eine Rendite von 29.1 erzielte.
Preisvolatilität Is NVLG's price volatile compared to industry and market? NVLG volatility NVLG Average Weekly Movement 4.2% Healthcare Industry Average Movement 3.5% Market Average Movement 4.0% 10% most volatile stocks in IL Market 7.5% 10% least volatile stocks in IL Market 2.8%
Stabiler Aktienkurs: NVLG hat in den letzten 3 Monaten keine nennenswerten Preisschwankungen aufgewiesen.
Volatilität im Zeitverlauf: NVLGDie wöchentliche Volatilität (4%) ist im vergangenen Jahr stabil geblieben.
Über das Unternehmen Novolog (Pharm-Up 1966) Ltd bietet Gesundheitsdienstleistungen in Israel an. Das Unternehmen ist in drei Geschäftsbereichen tätig: Logistik, Gesundheitsdienste und Digitales. Der Geschäftsbereich Logistik befasst sich mit dem Import und Vertrieb von Arzneimitteln und medizinischen Produkten, der Logistik von klinischen Studien und damit verbundenen Dienstleistungen, der Erbringung von pharmazeutischen Dienstleistungen für Kunden sowie Sterilisations- und Validierungsverfahren für medizinische Verbrauchsgüter.
Mehr anzeigen Novolog (Pharm-Up 1966) Ltd's Grundlagenzusammenfassung Wie verhalten sich die Erträge und Einnahmen von Novolog (Pharm-Up 1966) im Vergleich zum Marktanteil des Unternehmens? NVLG grundlegende Statistiken Marktanteil ₪801.83m Gewinn(TTM ) -₪17.54m Umsatz(TTM ) ₪1.68b
0.5x Kurs-Umsatz-Verhältnis
-45.7x Kurs-Gewinn-Verhältnis Erträge & Einnahmen Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM) NVLG Gewinn- und Verlustrechnung (TTM ) Einnahmen ₪1.68b Kosten der Einnahmen ₪1.51b Bruttogewinn ₪173.56m Sonstige Ausgaben ₪191.10m Umsatz -₪17.54m
Zuletzt gemeldete Gewinne
Jun 30, 2024
Datum des nächsten Gewinnberichts
Nov 20, 2024
Gewinn per Aktie (EPS) -0.034 Bruttomarge 10.31% Nettogewinnspanne -1.04% Schulden/Eigenkapital-Verhältnis 0.03%
Wie hat sich NVLG auf lange Sicht entwickelt?
Historische Performance und Vergleiche Dividenden
3.7% Aktuelle Dividendenrendite
Simply Wall St™ Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
{"enabled":true,"variant":{"name":"display-ssr-flag","enabled":true,"feature_enabled":true,"featureEnabled":true},"flagsReady":true,"flagsError":null}
